BD unveils ultrasound tech for IV insertions

2023-04-11
The new, easy-to-use, advanced ultrasound device — called the Prevue II — features a special probe. BD designed the Prevue II to address an unmet need in IV access through real-time needle depth markers. Franklin Lakes, New Jersey-based BD’s system includes the Cue needle tracking system. This offers high-quality ultrasound imaging of the needle trajectory. It also has compatibility with Cue needle tracking-enabled catheters. The company said simulated studies demonstrated that pairing a needle-tracking system with ultrasound guidance can help reduce the number of attempts and time to successful vessel access. Citing the American Institute of Ultrasound in Medicine, BD said this may make vascular access procedures safer and easier. BD designed the system with “clinician-friendly” features to expand the use of ultrasound in IV placement. Prevue II’s specialized probe helps reduce the learning curve. This ensures that clinicians can use the technology without changing their insertion technique or field of view. “Difficult IV access remains far too common today, but the availability of the BD Prevue II System supports a future where every needlestick has a predefined pathway for successful placement,” said Eric Borin, worldwide president of medication delivery solutions. “BD is advancing the vision of a ‘One-Stick Hospital Stay,’ and first-stick success is the first requirement to fulfill that vision. First-stick success also reduces the pain and anxiety patients often experience while undergoing multiple IV access attempts and provides clinicians with IV workflow efficiencies and confidence.” BD aims to reduce unnecessary needlesticks by choosing the right vascular access device and placing it successfully the first time. about BD’s “One-Stick Hospital Stay” initiative here.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。